Congressional psychedelics bill; VA marijuana resentencing; DE Senate overrides cannabis veto; FL vets medical marijuana discount; Craft cannabis oped
Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day.
Your support makes Marijuana Moment possible…
BREAKING: Journalism is often consumed for free, but costs money to produce! While this newsletter is proudly sent without cost to you, our ability to send it each day depends on the financial support of readers who can afford to give it. So if you’ve got a few dollars to spare each month and believe in the work we do, please consider joining us on Patreon today.
https://www.patreon.com/marijuanamoment
/ TOP THINGS TO KNOW
The Department of Justice has no “comment or updates” on the cannabis rescheduling process, a spokesperson told Marijuana Moment—more than a month after President Donald Trump signed an executive order directing Attorney General Pam Bondi to complete the process “in the most expeditious manner.”
Reps. Jack Bergman (R-MI) and Lou Correa (D-CA) filed a bill directing the Department of Veterans Affairs to carry out clinical trials on the therapeutic efficacy of “innovative treatments and emerging therapies”—including psychedelics such as ibogaine, 5-MeO-DMT, ketamine and psilocybin.
The Delaware Senate voted to override Gov. Matt Meyer’s (D) veto of a marijuana bill to block restrictive business zoning rules in counties.
The Virginia House Court of Justice Committee approved a bill to provide resentencing relief for people incarcerated or on community supervision for certain marijuana offenses as lawmakers separately prepare to legalize recreational cannabis sales.
The Florida House Health Professions & Programs Subcommittee unanimously approved a bill to slash medical cannabis patient registration fees for military veterans—with the sponsor saying it will help them access “a much better way of dealing with their medical issues” than opioids.
A coalition of gun rights groups led by the Second Amendment Foundation filed a brief urging the U.S. Supreme Court to strike down the federal law barring marijuana consumers from purchasing and possessing firearms as unconstitutional.
Former New York cannabis regulator Damian Fagon argues in a new Marijuana Moment op-ed that “‘craft cannabis’ functions far more as a marketing label than as a stable economic segment” and that “the erosion of small cannabis producers reflects policy design choices” that favor big companies.
The South Carolina House Judiciary Committee approved two hemp bills—one to broadly ban THC products and another that provides an exception for intoxicating cannabis beverages.
/ FEDERAL
A spokesperson for Health and Human Services Secretary Robert F. Kennedy Jr. reacted to advocates’ frustration about the lack of Trump administration progress on psychedelics reform by saying he “shares the goal of ensuring that all Americans—especially our nation’s veterans—have access to safe and effective treatments for conditions such as PTSD, addiction, and depression.”
Rep. Tim Burchett (R-TN) posted a video pushing back on the notion that marijuana legalization can raise revenue to support programs.
/ STATES
Ohio Gov. Mike DeWine (R) said he is open to having conversations about allowing hemp-infused drinks, but that he will “go in with a bias” and said the products are “not necessarily comparable to alcohol.”
The Florida Senate Criminal Justice Committee approved a bill to decriminalize drug testing products.
New Mexico senators are dedicating portions of their budget allotments to the Medical Psilocybin Treatment Equity Fund.
Wisconsin senators discussed their support for regulating cannabinoid products.
Oklahoma lawmakers are considering several bills to revise medical cannabis rules this session.
Hawaii regulators are being sued over a hemp product restriction law.
Rhode Island regulators are moving to repeal outdated hemp jurisdiction rules.
Illinois regulators are extending the deadline for craft cannabis growers to become operational.
California regulators published an FAQ about the state’s hemp product restriction law.
Washington State regulators sent a newsletter with updates on various cannabis issues.
Rhode Island regulators will host a listening session about cannabis beverages on Monday.
—
Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.![]()
Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.
—
/ LOCAL
Jersey City, New Jersey’s mayor said the City Council should pass legislation to allow cannabis lounges to open.
/ INTERNATIONAL
A Canadian lawmaker is sponsoring a petition to raise the legal age for marijuana to 25, to ban production of cannabis edibles and to revoke licenses of companies due to odor.
/ SCIENCE & HEALTH
A study found that CBD is a “promising CDC123-eIF2γ inhibitor for colorectal cancer therapy.”
A study found that “cannabidiol reduces oxycodone self-administration while preserving its analgesic efficacy in a rat model of neuropathic pain.”
/ ADVOCACY, OPINION & ANALYSIS
The American Civil Liberties Union published a blog post urging the U.S. Supreme Court to overturn the federal law barring marijuana consumers from owning guns.
/ BUSINESS
Glass House Brands Inc. welcomed the chief marketing officer of Heineken, USA to its board of directors.
Trulieve Cannabis Corp. closed a second tranche of its private placement of senior secured notes in the principal amount of US$60.0 million.
/ CULTURE
Former basketball player Lamar Odom entered a drug rehabilitation program to help quit using marijuana following a DUI arrest.
Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox.















